| 
Results for multipple myeloma. Search took 0.11 seconds.
Stem Cell Therapy Reverse Multipple Sclerosis
in The Biotech Weblog, on January 31, 2009
Photo courtesy of iStockphoto , Image# 6634098 The Telegraph reports of the continuing positive results on the use of stem cells in treating multiple sclerosis in conjunction with a drug called alemtuzumab. The study leader, Dr Richard Burt, described it as a "feasible procedure" tha...
Moffitt's Free Leukemia, Lymphoma, Myeloma and Bone Marrow Transplantation Symposium
in Straightfromthedoc, on June 4, 2008
...What: "Leukemia, Lymphoma, Myeloma and Bone Marrow Transplantation" Free Educational Symposium
When: June 11, 2008 4-8 pm
Where: Moffitt's Stabile Research Building, 12902 Magnolia ...
REVLIMID® (lenalidomide)-Dexamethasone Combo, Effective in Multiple Myeloma
in Straightfromthedoc, on November 23, 2007
...oral drug lenalidomide (REVLIMID®), in combination with the steroid dexamethasone, multiple myeloma patients significantly improved by all measures where previous treatments had failed .
...
FISH-Based Test Identify Genetic Abnormalities in Plasma Cell Malignancies
in The Biotech Weblog, on October 28, 2007
...that is present.
The test should be applied to patients diagnosed with PCPD, particularly multiple myeloma, to determine the presence of genetic abnormalities that could offer insight into prognosis,...
The Leukemia & Lymphoma Society's Co-Pay Assistance Program
in Straightfromthedoc, on May 18, 2007
... Have you been diagnosed with any one of the following?
Myeloma
Hodgkin's lymphoma
Non-Hodgkin's lymphoma
Acute myelogenous leukaemia
Myelodysplastic syndromes (MDS)
...
Mold By-Product Chaetocin May Treat Myeloma
in The Biotech Weblog, on April 24, 2007
...ng, chaetocin , a by-product of a common wood mold, may hold promise as a new therapeutic against myeloma , an incurable bone marrow cancer .
Dr. Bible's team has shown for the first tim...
Morgan Stanley Expect Favorable Returns from Large Biotech Companies
in The Biotech Weblog, on July 20, 2006
...ics. Top products include Thalomid and Revlimid , both approved for the treatment of multiple myeloma, among others.
Read more about Morgan Stanley's report from the Forbes article ....
AnorMed Completes Patient Recruitment To Test MOZOBIL In Stem Cell Transplant For Multiple Myeloma
in The Biotech Weblog, on July 11, 2006
...is Phase III clinical trials for with MOZOBIL for stem cell transplant as treatment for Multiple Myeloma , a cancer of the plasma cells. MOZOBIL is a stem cell mobilizer used in stem cell transplan...
FDA Approves Thalomid For Multipple Myeloma Therapy
in The Biotech Weblog, on May 30, 2006
... Thalomid in combination with dexamethasone for the treatment of newly diagnosed multiple myeloma , a common type of blood cancer affecting about 50,000 patients in the US.
THALOMID is ava...